Pyruvate-utilizing metabolic enzymes (LDH/PDH/ALT)

This entry refers to a functional group of enzymes—primarily lactate dehydrogenase (LDH), pyruvate dehydrogenase (PDH), alanine aminotransferase (ALT), and pyruvate carboxylase (PC)—that catalyze the conversion of pyruvate into various metabolites (Nelson et al., 2017). In the context of diagnostic imaging and metabolic research, these enzymes are utilized for their tracer/substrate role, where hyperpolarized [1-13C]pyruvate is administered to monitor real-time metabolic flux in vivo (Kurhanewicz et al., 2011). LDH activity, which converts pyruvate to lactate, is a hallmark of the Warburg effect in cancer cells, where aerobic glycolysis is preferred over oxidative phosphorylation (Vander Heiden et al., 2009). PDH activity reflects the entry of pyruvate into the mitochondria for the tricarboxylic acid (TCA) cycle, serving as a critical indicator of oxidative capacity in cardiac and neurological tissues (Guglielmetti et al., 2017). By measuring the conversion rates of these substrates, clinicians can assess disease severity and therapeutic efficacy without directly inhibiting the enzymes themselves. Consequently, while these enzymes are vital metabolic nodes, the specific designation here emphasizes their utility as diagnostic tools rather than primary pharmacological targets.

Other names

Pyruvate metabolic pathway enzymesPyruvate flux enzymesEnzymes of pyruvate metabolismPyruvate-processing enzymes

These enzymes facilitate the chemical conversion of exogenous or endogenous pyruvate into metabolic products such as lactate, acetyl-CoA, alanine, and oxaloacetate, which are then measured via spectroscopic imaging to determine real-time metabolic flux (Kurhanewicz et al., 2011).